A case report of COVID-19 in refractory myasthenia: Outcome with remdesivir and dexamethasone

RATIONALE: Myasthenia gravis (MG) patients are at increased risk of COVID-19 infection and its complications due to chronic immunosuppression. COVID-19 infection can also increase the risk of myasthenia exacerbation. PATIENT CONCERNS: The patient presented with respiratory distress, fever and chills...

Descripción completa

Detalles Bibliográficos
Autores principales: Bhagavan, Sachin M., Ramaswamy, Swathi Beladakere, Govindarajan, Raghav
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
5300
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8104252/
https://www.ncbi.nlm.nih.gov/pubmed/33950951
http://dx.doi.org/10.1097/MD.0000000000025701

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8104252/
https://www.ncbi.nlm.nih.gov/pubmed/33950951
http://dx.doi.org/10.1097/MD.0000000000025701

Ejemplares similares